High materiality7/10
Versigent price target raised to $59 from $48 at Goldman Sachs
Why it may matterVerify against the original reporting
Upside potential supported by a higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs raises VGNT target to $59; current price is $45.62; upside implied by the target.
- Target: $59; Posted price: $45.62; Firm: Goldman Sachs
Key facts
- 01
Target: $59
- 02
Posted price: $45.62
- 03
Analyst firm: Goldman Sachs
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.